Clinical Trial Update: Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months

View source ↗

Summary

This completed clinical trial evaluated changes in metabolic parameters in patients with major depressive disorder, generalized anxiety disorder, or panic disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Panic Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Changi General Hospital | Conditions: Major Depression, Generalized Anxiety Disorder | Status: COMPLETED